Gamida Cell Ltd. (GMDA): Clinical Trial Saves Leukemia Patient...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

Gamida Cell Ltd. (GMDA)

Reply Private New

Next 10 Prev Next

Send PM

Followers	135
Posts	27005
Boards Moderated	5
Alias Born	02/07/2004

FREE
GMDA REPORT

Re: None

Tuesday, 10/04/2022 10:32:01 AM

Tuesday, October 04, 2022 10:32:01 AM

Clinical Trial Saves Leukemia Patient

After being diagnosed with high-risk leukemia, Jesus Torres needed a bone marrow transplant if he was to have any chance of a cure. Like many Hispanics, he faced challenges finding a matching donor in the international donor pool. Fortunately, his hematologist Patrick Hagen, MD, was able to enroll Jesus in a clinical trial studying a new treatment using umbilical cord blood as his donor source. Just three months after his transplant, Jesus had no signs of leukemia and is living a normal life now.

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent GMDA News

Current Report Filing (8-k) • Edgar (US Regulatory) • 03/27/2023 11:16:25 AM
Gamida Cell Reports Full Year 2022 Financial Results and Provides Company Update • Business Wire • 03/27/2023 11:00:00 AM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/22/2023 08:35:41 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 08:46:51 PM
Gamida Cell Announces Changes to Board of Directors • Business Wire • 03/20/2023 08:30:00 PM
Gamida Cell Announces the Date of Its Fourth Quarter and Full Year 2022 Financial Results and Webcast • Business Wire • 03/20/2023 12:00:00 PM
Gamida Cell to Present Corporate Highlights at the Oppenheimer 33rd Annual Healthcare Conference • Business Wire • 03/07/2023 01:00:00 PM
Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 03/03/2023 09:03:47 PM
Data Presented on Gamida Cell’s Omidubicel, GDA-201 at the 2023 Tandem Meetings of ASTCT and CIBMTR • Business Wire • 02/18/2023 05:30:00 PM
Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/14/2023 09:10:55 PM
Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:02:40 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 01/30/2023 12:03:54 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/30/2023 12:01:20 PM
Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:06 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 01/20/2023 09:32:22 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/19/2023 09:44:26 PM
Proxy Statement (definitive) (def 14a) • Edgar (US Regulatory) • 01/10/2023 10:13:59 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 01/09/2023 05:16:06 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) • Edgar (US Regulatory) • 12/30/2022 10:17:38 PM
Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Arcutis Biotherapeutics (ARQT) • TipRanks • 12/12/2022 06:11:45 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/12/2022 12:16:53 PM
Gamida Cell Announces Closing of $25 Million Financing With Highbridge • Business Wire • 12/12/2022 12:00:00 PM
Gamida Cell to Present Corporate Highlights at Multiple Upcoming Investor Conferences • Business Wire • 11/23/2022 01:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:37:38 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 11/22/2022 09:35:07 PM

More GMDA News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!